Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates

Transplantation

Volumn 74, Issue 7, 2002, Pages 940-943

  Xu, He ^a   Tadaki, Douglas K ^a   Elster, Eric A ^a   Burkly, Linda C ^b   Berning, Justin D ^a   Cruzata, Francis ^a   Kampen, Robert L ^a   Montgomery, Sean P ^a   Patterson, Noelle B ^a   Harlan, David M ^a   Kirk, Allan D ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b BIOGEN   (United States)

^c Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HU5C8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; TREATMENT FAILURE;

EID: 0037108936     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200210150-00007     Document Type: Article

References (10)

1. Alderson MR, Armitage RJ, Tough TW, et al. CD40 expression by monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669.
2. Hollenbaugh D, Mischel-Petty N, Edwards C, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33.
3. Nishioka Y, Lipsky PE. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol 1994; 153: 1027.
4. Roy M, Waldschmidt T, Aruffo A, et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993, 151: 2497.
5. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591.
6. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
7. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
8. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94: 8789.
9. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med 1999; 5: 686.
10. He Xu, Elster EA, Batty DS, et al. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. Transplant Proc 2001; 33: 223.